全文获取类型
收费全文 | 657篇 |
免费 | 35篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 10篇 |
妇产科学 | 7篇 |
基础医学 | 85篇 |
口腔科学 | 3篇 |
临床医学 | 65篇 |
内科学 | 240篇 |
皮肤病学 | 5篇 |
神经病学 | 13篇 |
特种医学 | 16篇 |
外科学 | 141篇 |
综合类 | 5篇 |
预防医学 | 30篇 |
眼科学 | 11篇 |
药学 | 25篇 |
肿瘤学 | 27篇 |
出版年
2023年 | 12篇 |
2022年 | 16篇 |
2021年 | 38篇 |
2020年 | 15篇 |
2019年 | 23篇 |
2018年 | 18篇 |
2017年 | 13篇 |
2016年 | 20篇 |
2015年 | 19篇 |
2014年 | 29篇 |
2013年 | 29篇 |
2012年 | 45篇 |
2011年 | 63篇 |
2010年 | 29篇 |
2009年 | 18篇 |
2008年 | 50篇 |
2007年 | 41篇 |
2006年 | 32篇 |
2005年 | 40篇 |
2004年 | 31篇 |
2003年 | 37篇 |
2002年 | 18篇 |
2001年 | 4篇 |
2000年 | 7篇 |
1998年 | 2篇 |
1997年 | 4篇 |
1993年 | 1篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1986年 | 2篇 |
1984年 | 2篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1973年 | 4篇 |
1972年 | 2篇 |
1971年 | 3篇 |
1970年 | 4篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1966年 | 1篇 |
1965年 | 1篇 |
1958年 | 2篇 |
1955年 | 1篇 |
1922年 | 1篇 |
排序方式: 共有698条查询结果,搜索用时 15 毫秒
1.
Vlad C. Sandulache PhD ; Aron Parekh PhD ; HaSheng Li-Korotky MD PhD ; Joseph E. Dohar MD MS ; Patricia A. Hebda PhD 《Wound repair and regeneration》2007,15(1):122-133
Keloid formation has been linked to aberrant fibroblast activity, exacerbated by growth factors and inflammatory mediators. Prostaglandin E2 (PGE2), synthesized from arachidonic acid by cyclooxygenases (COX) and synthases (PGES), acts as both an inflammatory mediator and fibroblast modulator. Although PGE2 has known antifibrotic effects in the lower airway, its role in dermal fibrosis in general, and keloid formation in particular, remains unclear. This study focused on: (1) the effects of PGE2 on keloid fibroblast migration, contraction, and collagen synthesis and (2) endogenous PGE2 synthesis in response interleukin-1beta. PGE2 decreased keloid fibroblast migration and contraction via an EP2/EP4-cAMP mechanism that disrupted actin cytoskeletal dynamics and reversed transforming growth factor-beta1-induced collagen I and III synthesis. Impaired fibroblast PGE2 production has been linked to lower airway fibrosis and recently to keloid formation. Here, we showed that interleukin-1beta stimulation leads to nuclear factor-kappaB translocation to the nucleus, resulting in up-regulation of COX-2 and microsomal PGE2 synthase 1. Up-regulation of COX-2 in, and secretion of PGE2 by keloid fibroblasts are diminished compared with their normal fibroblast counterparts. We suggest that the antifibrotic effects of PGE2 during keloid formation are potentially diminished due to aberrant paracrine fibroblast signaling. Exogenous PGE2 may supplement decreased endogenous levels and inhibit keloid formation or progression. 相似文献
2.
Simona Gurzu Tivadar Bara Calin Molnar Tivadar Bara Vlad Butiurca Hanga Beres Simin Savoji Ioan Jung 《Pathology, research and practice》2019,215(1):82-89
Background
Pancreatic mucinous cystic neoplasms (MCN) are rare tumors that are usually diagnosed in females.Materials and methods
In our department, only four of the 109 consecutive cases of pancreatic tumors (3.67%) were diagnosed as MCNs. In this report, we present the characteristics of these four specific cases which also showed unusual HER-2 positivity and neuroendocrine differentiation.Results
The four MCNs were diagnosed in patients with ages between 46 and 75 years. Other clinical particularities were the following: one benign case, splenic rupture as result of a giant cystic tumor on the tail of the pancreas directly invading the spleen in the second one, metastases in the accessory spleen in the third one and invasion of the abdominal vessels in the fourth case. In all of these cases, the ovarian-like stroma tested positivity for calretinin, progesterone receptor (PR) and, in cases 2 and 3, for AE1/AE3 keratin. The malignant tumor cells were marked by carcinoembryonic antigen, HER-2, maspin, PR and the neuroendocrine markers synaptophysin, CD56, and neuron-specific enolase.Conclusions
These cases highlight the unusually aggressive behavior of pancreatic MCN with invasive carcinomas that share mixed exo- and endocrine components and show epithelial-mesenchymal transition. 相似文献3.
Vlad Vasiliu Peter Herzer Dieter Rössler Gisela Lehnert B. Wilske 《Medical microbiology and immunology》1998,187(2):97-102
Borrelia burgdorferi sensu lato, the etiological agent of Lyme borreliosis, has been divided into three genospecies: B. burgdorferi sensu stricto (OspA-type 1), B. afzelii (OspA-type 2) and B. garinii (OspA-type 3–7). Whereas in Europe B. afzelii (OspA-type 2) is predominant among human skin isolates and B. garinii (OspA-type 3–7) among human CSF isolates, some previous serological studies suggested that Lyme arthritis is also associated
with B. burgdorferi sensu stricto in Europe. In the present study we designed ospA type-specific PCRs and identified four different ospA types associated with Lyme arthritis. Our study group consisted of 20 patients with positive serology (ELISA and immunoblotting)
and clinical criteria for Lyme arthritis. B. burgdorferi DNA was detected in 13 patients and in none of 10 control patients from synovial fluid. We identified ospA-type 1 (26.6%), ospA-type 2 (33.3%), ospA-type 4 (6.6%) and ospA-type 5 (33.3%). Our conclusion is that in Europe B. burgdorferi sensu lato strains causing Lyme arthritis are considerably heterogeneous and that there is no prevalence of certain genospecies
or OspA-types among this strains.
Received: 14 May 1998 相似文献
4.
Robert Pearson John Asher Andrew Jackson Patrick B. Mark Vlad Shumeyko Marc J. Clancy 《American journal of transplantation》2021,21(3):1317-1321
The role of ex vivo normothermic perfusion (EVNP) in both organ viability assessment and reconditioning is increasingly being demonstrated. We report the use of this emerging technology to facilitate the transplantation of a pair of donor kidneys with severe acute kidney injury (AKI) secondary to rhabdomyolysis. Donor creatinine was 10.18 mg/dl with protein (30 mg/dl) present in urinalysis. Both kidneys were declined by all other transplantation units and subsequently accepted by our unit. The first kidney was perfused with red cell-based perfusate at 37°C for 75 min, mean renal blood flow was 110 ml/min/100 g and produced 85 ml of urine. Having demonstrated favorable macroscopic appearance and urine output, the kidney was transplanted into a 61-year-old peritoneal dialysis dependent without complication. Given the reassuring information from the first kidney provided by EVNP, the second kidney was not perfused with EVNP and was directly implanted to a 64-year-old patient. The first kidney achieved primary function and the second functioned well after delayed graft function. Recipient eGFR have stabilized at 88.5 and 55.3, respectively (ml/min/1.73 m2), at 2 months posttransplant. 相似文献
5.
6.
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. 总被引:13,自引:0,他引:13
Matthew P Goetz David Toft Joel Reid Matthew Ames Bridget Stensgard Stephanie Safgren Araba A Adjei Jeff Sloan Pamela Atherton Vlad Vasile Sandra Salazaar Alex Adjei Gary Croghan Charles Erlichman 《Journal of clinical oncology》2005,23(6):1078-1087
PURPOSE: We determined the maximum-tolerated dose (MTD) and the dose-limiting toxicities (DLT) of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when infused on days 1, 8, and 15 of a 28-day cycle in advanced solid tumor patients. We also characterized the pharmacokinetics of 17-AAG, its effect on chaperone and client proteins, and whether cytochrome P450 (CYP) 3A5 and NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphisms affected 17-AAG disposition or toxicity. PATIENTS AND METHODS: An accelerated titration design was used. Biomarkers were measured in peripheral-blood mononuclear cells (PBMCs) at baseline and on days 1 and 15, and pharmacokinetic analysis was performed on day 1 of cycle 1. CYP3A5*3 and NQO1*2 genotypes were determined and correlated with pharmacokinetics and toxicity. RESULTS: Twenty-one patients received 52 courses at 11 dose levels. DLTs at 431 mg/m(2) were grade 3 bilirubin (n = 1), AST (n = 1), anemia (n = 1), nausea (n = 1), vomiting (n = 1), and myalgias (n = 1). No tumor responses were seen. 17-AAG consistently increased heat shock protein (Hsp) 70 levels in PBMCs. At the MTD, the clearance and half-life (t(1/2)) of 17-AAG were 11.6 L/h/m(2) and 4.15 hours, respectively; whereas the active metabolite 17-aminogeldanamycin had a t(1/2) of 7.63 hours. The CYP3A5*3 and NQO1*2 polymorphisms were not associated with 17-AAG toxicity. The CYP3A5*3 polymorphism was associated with higher 17-AAG clearance. CONCLUSION: The MTD of weekly 17-AAG is 308 mg/m(2). 17-AAG induced Hsp70 in PBMCs, indicating that Hsp90 has been affected. Further evaluation of 17-AAG is ongoing using a twice-weekly regimen, and this schedule of 17-AAG is being tested in combination with chemotherapy. 相似文献
7.
8.
9.